T-Cell Specific Surface Glycoprotein CD28 Market 2021 Growth, COVID Impact, Trends Analysis Report 2027
The global T-cell specific surface glycoprotein CD28 market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). CD28 is a glycoprotein of 90 kDa and occurs naturally as a disulfide-linked homodimer of a polypeptide that contains a single Ig-like extracellular domain. Additionally, it is a member of the Ig superfamily and is expressed on T cells that provide co-stimulatory signals which are required for T cell activation and survival. Furthermore, it acts as a major costimulation pathway for naive T-cell activation while playing a central role in immune responses against pathogens, autoimmune diseases, and graft rejection.
Moreover, it enhances the
production of IL4 and IL10 in T-cells in conjunction. Additionally, it signals the
initial activation of naive CD4 T cells by increasing the sensitivity of the T
cell to antigen receptor engagement. Furthermore, CD28 is expressed on 50% of
CD8+ T cells and more than 80% CD4+ T cells in humans and supports to kill
cancer cells that are virally infected or that are under damage. Hence, the
factor driving the growth of the market is the prevalence of cancer.
To Request a Sample of our Report on T-Cell Specific
Surface Glycoprotein CD28 Market: https://www.omrglobal.com/request-sample/t-cell-specific-surface-glycoprotein-cd28-market
According to the National Cancer Institute (NCI), it was
estimated that 1,806,590 new cases of cancer will be diagnosed in the US in
2020. Furthermore, there were 18.1 million new cases and 9.5 million
cancer-related mortalities globally in 2018 which is anticipated to rise to
29.5 million and the number of cancer-related mortalities to 16.4 million by 2040.
Some major players in the market include Bristol-Myers Squibb Co., and Johnson
and Johnson Services, Inc., among others.
Market Coverage
·
The market number available for – 2020-2027
·
Base year- 2020
·
Forecast period- 2021-2027
Segment Covered-
·
By Type
·
By Application
Regions Covered-
·
North America
·
Europe
·
Asia-Pacific
·
Rest of the World
Competitive Landscape- Amgen Inc., and Johnson &
Johnson Services, Inc., among others.
(Get 15% Discount on Buying this Report)
A
full Report of T-Cell Specific Surface Glycoprotein CD28 Market is Available
@ https://www.omrglobal.com/industry-reports/t-cell-specific-surface-glycoprotein-cd28-market
Global T-Cell Specific Surface Glycoprotein CD28 Market
Report by Segment
By Type
• FPT-155
• FR-104
• Lulizumab
Pegol
• Others
By Application
• Plaque
Psoriasis
• Solid
Tumor
• Acute
Renal Failiure(ARF)
• Others
Global T-Cell Specific Surface Glycoprotein CD28 Market
Report by Region
North America
·
United States
·
Canada
Europe
·
UK
·
Germany
·
Spain
·
France
·
Italy
·
Rest of Europe
Asia-Pacific
·
India
·
China
·
Japan
·
South Korea
·
Rest of APAC
Rest of the World
·
Latin America
·
Middle East & Africa
Reasons to buy from us –
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other
research-based services.
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment